NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway

Hepatocellular carcinoma (HCC) is one of the most prevalent and aggressive malignant tumors. The involvement of N-myc (and STAT) interactor (NMI) and its possible functional mechanisms in HCC progression still remain to be elucidated. In this study, we found that NMI was overexpressed in metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Dong, Qiong-Zhu, Zhong, Fan, Cai, Li-Li, Qin, Zhao-Yu, Liu, Yang, Lin, Cheng-Zhao, Qin, Lun-Xiu, He, Fu-Chu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355334/
https://www.ncbi.nlm.nih.gov/pubmed/28077802
http://dx.doi.org/10.18632/oncotarget.14556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355334/
https://www.ncbi.nlm.nih.gov/pubmed/28077802
http://dx.doi.org/10.18632/oncotarget.14556

Ejemplares similares